Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pain × Palonosetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 13 Nausea 11 Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Multiple Myeloma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Radiation Injuries 1 Pancreatic Neoplasms 1 Pain 1 Neoplasms, Germ Cell and Embryonal 1 Nausea With Vomiting Chemotherapy-Induced 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Glioma 1 Gallbladder Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Brain Neoplasms 1 Bile Duct Neoplasms 1 Appendiceal Neoplasms 1 Anus Neoplasms 1

Interventions

Morphine 6 Analgesia 6 nabiximols 3 Pregabalin 3 Oxycodone 3 Fentanyl 3 ziconotide 2 Surveys and Questionnaires 2 Saline Solution 2 Radiofrequency Ablation 2 Methadone 2 Lidocaine 2 Ketamine 2 Ibandronic Acid 2 Gemcitabine 2 Duloxetine Hydrochloride 2 Docetaxel 2 Botulinum Toxins, Type A 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 tanezumab 1 tandutinib 1 siltuximab 1 resiniferatoxin 1 incobotulinumtoxinA 1 imisopasem manganese 1 fulranumab 1 erenumab 1 cyclobenzaprine 1 caffeine, sodium benzoate drug combination 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05315999 2025-03-19

ProTreat

University Hospital Freiburg

Phase 2 Completed

Nausea, Pain, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡